Healthconn Corp. (TPEX:6665)
18.15
0.00 (0.00%)
Aug 19, 2026, 10:03 AM CST
Healthconn Revenue
Healthconn had revenue of 583.06M TWD in the half year ending December 31, 2025, a decrease of -8.20%. This brings the company's revenue in the last twelve months to 1.17B, down -2.54% year-over-year. In the year 2025, Healthconn had annual revenue of 1.13B, down -9.76%.
Revenue (ttm)
1.17B
Revenue Growth
-2.54%
P/S Ratio
0.70
Revenue / Employee
5.72M
Employees
205
Market Cap
823.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | -122.32M | -9.76% |
| Dec 31, 2024 | 1.25B | -2.51M | -0.20% |
| Dec 31, 2023 | 1.26B | -289.50M | -18.73% |
| Dec 31, 2022 | 1.55B | 182.35M | 13.38% |
| Dec 31, 2021 | 1.36B | -144.18M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Kim Forest Enterprise | 599.63M |
| Yung Zip Chemical Ind. | 494.04M |
| Meribank Biotech | 471.76M |
| Radiant Innovation | 389.45M |
| Taiwan Advance Bio-Pharmaceutical | 364.79M |
| TCI GENE | 251.39M |
| NatureWise Biotech & Medicals | 176.77M |